Shares of Aurora Cannabis Inc. ACB rose 7.45% to $5.05 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.40% ...

Aurora Cannabis Inc. closed 34.72% short of its 52-week high of $7.20, which the company reached on August 15th.

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of two new proprietary cultivars in Poland, marking the highest ...

Aurora Cannabis (Nasdaq: ACB) continued to fly high as it closed out fiscal 2025, with net revenue topping street estimates and prospects looking brighter as it progresses through the new year.

Aurora said global cannabis revenue in the current quarter will likely decline from the company’s fourth-quarter level as reduced international sales offset growing Canadian medical cannabis sales.

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has expanded their popular IndiMed brand with the launch of IndiMed TEMPO 22, available ...

The year is a more than a month old, but Aurora Cannabis (NASDAQ: ACB) is already one of the hottest stocks to own in 2025. As of Feb. 11, the pot stock has soared more than 50% since the year ...

Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB stock from hold to buy.

Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 4,520,000 shares, a growth of ...

Aurora Cannabis reported increased revenues from international cannabis sales for Q2 2025. Check out why I rate ACB stock as a Hold for now.

TD Securities initiated coverage of Aurora Cannabis (ACB) with a Buy rating and C$9 price target The company “has turned over a proverbial new leaf” following the reset in the cannabis ...